Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Prescription Monitoring Database Access topic
No spam. Unsubscribe anytime.
Committee briefed on bill to narrow who may access prescription-monitoring database
Summary
SB 322 would remove the state board of pharmacy's authority to authorize additional delegates to access the prescription monitoring database, leaving access to statutorily enumerated groups; the committee heard a brief and requested related minutes and written records.
The committee was briefed on Senate Bill 322, a measure drafted following review by the Joint Committee on Administrative Rules and Regulations (JCAR) that would remove the authority of the state board of pharmacy to authorize additional "delegates" to access the state's prescription monitoring program database. Jenna Moyer, Revisor in the Statutes Office, told the committee the bill amends KSA651682 and would restrict access to those groups identified in statute (health-care providers and death investigators, as cited) rather than allowing additional access by board rule.
The briefing noted the proposal stemmed from proposed regulations (cited in testimony as K68218) that raised concerns when they would have allowed additional categories of delegates, including possible addition of addiction counselors. Committee members asked staff to locate and circulate minutes from the June 10 meeting and other background materials. Elizabeth (committee member) said she could not find published minutes and attendees discussed the timing of the joint committee's action; the committee did not take a vote during the hearing.
Jenna said the board of pharmacy had not adopted the proposed regulation and that the bill was drafted after JCAR raised concerns; members were encouraged to read written testimony provided by Alexandra Blaz/Blazy and other materials before any further work on the bill. The hearing concluded with no formal action taken.
